Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHPA1.L Regulatory News (HPA1)

  • There is currently no data for HPA1

Total Voting Rights

3 Apr 2023 07:00

RNS Number : 0413V
Hambro Perks Acquisition Com Ltd
03 April 2023
 

3 April 2023

Hambro Perks Acquisition Company Limited (the "Company")

 

Total Voting Rights

 

In accordance with DTR 5.6.1R, and further to the announcement released on 24 March 2023, the total voting rights of the Company remain unchanged. There are 569,686 Ordinary Shares in issue, each with equal voting rights, and no shares held in Treasury.

This total voting rights figure can be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Hambro Perks Acquisition Company Limited

Peter Soliman, Company Secretary

 

peter@hambroperks.com

FTI Consulting (Financial PR advisor to HPAC)

Charles Palmer

Kit Dunford

 

 

+44 (0) 7976 743 360

+44 (0) 7717 417 038

 

About HPAC:

HPAC is a special purpose acquisition company incorporated as a non-cellular company limited by shares under the laws of the Island of Guernsey with number 69093 and for the purpose of acquiring a majority (or otherwise controlling) stake in a company or operating business through a merger, capital stock exchange, share purchase, asset acquisition, reorganisation or similar transaction. HPAC was admitted to trading on the standard listing segment of the main market for listed securities of the LSE on 30 November 2021.

 

For further information on HPAC, please see www.hpac.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRXLLFBXZLBBBF
Date   Source Headline
2nd May 20237:30 amRNSSuspension - Hambro Perks Acquisition Company
14th Apr 202312:55 pmRNSDirectorate Change
6th Apr 20232:52 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSTotal Voting Rights
30th Mar 20237:00 amRNSHolding(s) in Company
28th Mar 20234:59 pmRNSHolding(s) in Company
24th Mar 202311:20 amRNSTotal Voting Rights Clarification 24/03/2023
23rd Mar 202312:54 pmRNSVoting Rights Announcement
16th Mar 20235:33 pmRNSResults of Redemption Election
28th Feb 20231:24 pmRNSResults of Extraordinary General Meeting 28 Feb 23
22nd Feb 20232:41 pmRNSUpdate on Timetable for Potential Redemption
10th Feb 20237:00 amRNSNotice of EGM
8th Feb 20235:35 pmRNSHolding(s) in Company
5th Oct 20222:05 pmRNSResults of AGM
14th Sep 20227:00 amRNSFirst Annual General Meeting
25th Aug 20227:00 amRNSHalf-year Report
29th Jun 20227:00 amRNSAnnual Report & Audited Financial Statements
4th May 20224:59 pmRNSChange of Registered Office
11th Jan 20222:13 pmRNSHolding(s) in Company
7th Jan 20228:00 amRNSWarrants Admission to Trading
7th Jan 20227:00 amRNSConfirmation of Public Warrants
17th Dec 20217:00 amRNSConfirmation of Public Warrants Ex Date
10th Dec 20218:00 amRNSOverfunding Shares Admission to Trading
7th Dec 20218:00 amRNSOver-allotment Shares Admission to Trading
6th Dec 20214:59 pmRNSTR-1: Notification of major holdings
6th Dec 20213:59 pmRNSExercise of Over-allotment Option
6th Dec 20212:57 pmRNSTR-1: Notification of major holdings
3rd Dec 20214:38 pmRNSTR-1: Notification of major holdings
3rd Dec 20217:05 amRNSStabilisation Notice
3rd Dec 20217:00 amRNSExercise of Over-allotment Option
30th Nov 20218:00 amRNSShares Admission to Trading on the LSE
25th Nov 202112:23 pmRNSApproval and Publication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.